Bicycle Therapeutics is a holding company. Through its subsidiaries, Co. is a clinical-stage biopharmaceutical company developing a class of medicines, which it refers to as Bicycles. Bicycles are a therapeutic modality combining the pharmacology associated with a biologic with the manufacturing and pharmacokinetic properties of a small molecule. Co. is evaluating BT5528, a Bicycle Toxin Conjugate (BTC) targeting Ephrin type-A receptor 2, BT8009, a BTC™ targeting Nectin-4, and BT7480, a Bicycle tumor-targeted immune cell agonist® targeting Nectin-4 and agonizing CD137. In addition, BT1718, a BTC that is being developed to target tumors that express Membrane Type 1 matrix metalloproteinase. We show 1 historical shares outstanding datapoints in our BCYC shares outstanding history coverage, used to compute BCYC market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing BCYC market cap history over the course of time is important for investors
interested in comparing BCYC's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of BCYC versus a peer is one thing; comparing
BCYC market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like BCYC can fluctuate over the course of history.
With this page we aim to empower investors researching BCYC by allowing them to research the BCYC market cap history. |
Free BCYC Email Alerts:
Video: The Importance of Market Cap
